SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein

被引:16
|
作者
Walter, Marius [1 ,6 ]
Chen, Irene P. [2 ,3 ,4 ]
Vallejo-Gracia, Albert [2 ,3 ,4 ]
Kim, Ik-Jung [1 ]
Bielska, Olga [1 ]
Lam, Victor L. [3 ]
Hayashi, Jennifer M. [2 ,3 ,4 ]
Cruz, Andrew [1 ]
Shah, Samah [1 ]
Soveg, Frank W. [2 ,3 ,4 ]
Gross, John D. [3 ,5 ]
Krogan, Nevan J. [2 ,3 ,4 ,5 ]
Jerome, Keith R. [6 ,7 ]
Schilling, Birgit [1 ]
Ott, Melanie [2 ,3 ,4 ,8 ]
Verdin, Eric [1 ]
机构
[1] Buck Inst Res Aging, Novato, CA 94945 USA
[2] Gladstone Inst, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
[5] Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94143 USA
[6] Fred Hutch Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA
[7] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[8] Chan Zuckerberg Biohub, San Francisco, CA USA
关键词
FUNCTIONAL-ANALYSIS; RNA VIRUS; CORONAVIRUS; EXORIBONUCLEASE; DESUCCINYLATION; METABOLISM; PROMOTES; EXCISION;
D O I
10.1371/journal.ppat.1010811
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 non structural protein Nsp14 is a highly conserved enzyme necessary for viral replication. Nsp14 forms a stable complex with non-structural protein Nsp10 and exhibits exoribonuclease and N7-methyltransferase activities. Protein-interactome studies identified human sirtuin 5 (SIRT5) as a putative binding partner of Nsp14. SIRT5 is an NAD-dependent protein deacylase critical for cellular metabolism that removes succinyl and malonyl groups from lysine residues. Here we investigated the nature of this interaction and the role of SIRT5 during SARS-CoV-2 infection. We showed that SIRT5 interacts with Nsp14, but not with Nspl 0, suggesting that SIRT5 and Nsp10 are parts of separate complexes. We found that SIRT5 catalytic domain is necessary for the interaction with Nsp14, but that Nsp14 does not appear to be directly deacylated by SIRT5. Furthermore, knock-out of SIRT5 or treatment with specific SIRT5 inhibitors reduced SARS-CoV-2 viral levels in cellculture experiments. SIRT5 knock-out cells expressed higher basal levels of innate immunity markers and mounted a stronger antiviral response, independently of the Mitochondrial Antiviral Signaling Protein MAVS. Our results indicate that SIRT5 is a proviral factor necessary for efficient viral replication, which opens novel avenues for therapeutic interventions.
引用
收藏
页数:30
相关论文
共 50 条
  • [31] Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase
    Singh, Isha
    Li, Fengling
    Fink, Elissa A.
    Chau, Irene
    Li, Alice
    Rodriguez-Hernandez, Annia
    Glenn, Isabella
    Zapatero-Belinchon, Francisco J.
    Rodriguez, M. Luis
    Devkota, Kanchan
    Deng, Zhijie
    White, Kris
    Wan, Xiaobo
    Tolmachova, Nataliya A.
    Moroz, Yurii S.
    Kaniskan, H. Umit
    Ott, Melanie
    Garcia-Sastre, Adolfo
    Jin, Jian
    Fujimori, Danica Galonic
    Irwin, John J.
    Vedadi, Masoud
    Shoichet, Brian K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 7785 - 7803
  • [32] SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-KB activation
    Tofaute, Marie J.
    Weller, Benjamin
    Grass, Carina
    Halder, Hridi
    Dohai, Bushra
    Falter-Braun, Pascal
    Krappmann, Daniel
    BIOSCIENCE REPORTS, 2024, 44 (01)
  • [33] A High-Throughput Screening Pipeline to Identify Methyltransferase and Exonuclease Inhibitors of SARS-CoV-2 NSP14
    Hanson, Quinlin
    Hu, Xin
    Pal, Sourav
    Recabo, Katlin
    Ye, Lin
    Poon, Ivy
    Denson, John-Paul
    Messing, Simon
    Shen, Min
    Wilson, Kelli M.
    Zakharov, Alexey
    Esposito, Dominic
    Martinez, Natalia J.
    BIOCHEMISTRY, 2025, 64 (02) : 419 - 431
  • [34] The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors
    Otava, Tomas
    Sala, Michal
    Li, Fengling
    Fanfrlik, Jindrich
    Devkota, Kanchan
    Perveen, Sumera
    Chau, Irene
    Pakarian, Paknoosh
    Hobza, Pavel
    Vedadi, Masoud
    Boura, Evzen
    Nencka, Radim
    ACS INFECTIOUS DISEASES, 2021, 7 (08): : 2214 - 2220
  • [35] Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
    Shannon, Ashleigh
    Nhung Thi-Tuyet Le
    Selisko, Barbara
    Eydoux, Cecilia
    Alvarez, Karine
    Guillemot, Jean-Claude
    Decroly, Etienne
    Peersen, Olve
    Ferron, Francois
    Canard, Bruno
    ANTIVIRAL RESEARCH, 2020, 178
  • [36] SARS-CoV-2非结构蛋白NSP14的生物信息学分析
    许勇
    李静
    王红萍
    张忠东
    王娟
    胡倩
    赵娜娜
    生物技术通讯, 2020, 31 (02) : 178 - 182
  • [37] Structural biology of SARS-CoV-2 exoribonuclease/N7-methyltransferase (nsp14), 2′-O-methyltransferase (nsp16) and their enhancing protein (nsp10)
    Fyfe, Cameron
    von Soosten, Lea C.
    Santoni, Gianluca
    Thorn, Andrea
    CRYSTALLOGRAPHY REVIEWS, 2023, 29 (03) : 111 - 127
  • [38] Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase
    Basu, Souradeep
    Mak, Tiffany
    Ulferts, Rachel
    Wu, Mary
    Deegan, Tom
    Fujisawa, Ryo
    Tan, Kang Wei
    Lim, Chew Theng
    Basier, Clovis
    Canal, Berta
    Curran, Joseph F.
    Drury, Lucy S.
    McClure, Allison W.
    Roberts, Emma L.
    Weissmann, Florian
    Zeisner, Theresa U.
    Beale, Rupert
    Cowling, Victoria H.
    Howell, Michael
    Labib, Karim
    Diffley, John F. X.
    BIOCHEMICAL JOURNAL, 2021, 478 (01) : 2481 - 2497
  • [39] Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry
    Scholle, Michael D.
    Liu, Cheng
    Deval, Jerome
    Gurard-Levin, Zachary A.
    SLAS DISCOVERY, 2021, 26 (06) : 766 - 774
  • [40] Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load
    Eskier, Doga
    Suner, Asli
    Oktay, Yavuz
    Karakulah, Gokhan
    PEERJ, 2020, 8